Skip to content
‹ Back to IndustriesSciences

Demands of Smartphone Camera Quality Drive Manufacturing Process Improvements

The article discusses the improvements in smartphone camera quality and how these demands are driving advancements in manufacturing processes. ZYGO, an optical technology company, is using its Compass microlens process metrology system to ensure that these manufacturing processes meet industry standards. This system helps in controlling the production of high-performance imaging camera modules in smartphones.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

Promoted content from SMART Technologies on MarketScale.

By Sciences · · Promoted Content
Share
Demands of Smartphone Camera Quality Drive Manufacturing Process Improvements

Key takeaways

01

One billion smartphones are shipped each year, resulting in countless pictures taken.

02

Cell phone image quality has significantly improved in recent years.

03

ZYGO uses its Compass microlens process to maintain precision in smartphone camera manufacturing.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

With one billion smartphones shipped every year, there are an infinite number of pictures taken by these handheld devices as well. And in the past few years, cell phone image quality has undergone vast improvements. While the average consumer may not have noticed these enhancements, ZYGO has.

Not just because we’re an optical technology company who happen to make clever, innovative products. Rather, it’s because we get to see how our efforts impact the daily lives of millions of people as they capture life’s moments via their smart, but seemingly simple, phones.

Amazingly, these seemingly simple devices are packed with exceedingly smart technologies – one of which is the versatile camera lens module. Each smartphone’s camera lens module consists of multiple discrete lens elements that work in unison to provide high-performance imaging.

We are introducing our solution to the industry, and ultimately consumers – the Compass™ microlens process metrology system. The Compass system in an on-line production control tool that enables the rapid measurement and control of critical micro lenses and lens molds, ensuring that design parameters are being met while keeping the manufacturing process in control.

The Compass system employs proprietary and innovative ZYGO optical technology to uphold the precision, automation, and production throughput standards that can meet both current and future industry needs.

To ensure superior selfies, both now and beyond, check out the revolutionary ZYGO Compass™ micro lens process metrology system.

Read more at zygo.com

SMART Technologies

Part of this channel

SMART Technologies

Interactive learning technology trusted by educators worldwide

Visit the channel

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Adding Genmab's petosemtamab to Keytruda cut head and neck cancer death risk in half

Adding Genmab's petosemtamab to Keytruda cut head and neck cancer death risk in half

Genmab's petosemtamab, added to Merck's Keytruda, cut the risk of death by 50% in 699 first-line head and neck cancer patients. The trial held regardless of HPV status. Full data will be presented at an upcoming medical meeting.

  • 01In a cancer where median survival runs about 10 to 12 months, adding petosemtamab to Keytruda halved the risk of death at the first interim look.
  • 02The benefit held regardless of HPV status, supporting use in PD-L1-positive patients without separating by HPV status.
  • 03The figure to watch at the full-data presentation is median overall survival in each arm, because the topline release reports only the hazard ratio.

Nov 9, 2026

UCB commits to Veeva Vault CRM for unified engagement

UCB commits to Veeva Vault CRM for unified engagement

UCB has committed to Veeva Vault CRM, which Veeva’s release presents as an agentic CRM platform to drive unified engagement worldwide. UCB and Veeva executives describe it as a stable foundation for UCB’s commercial strategy, while the AI claims, including the Agentic Call Report, come from Veeva’s product description. No go-live date or financial terms were given.

  • 01The executive statements focus on Vault CRM as a foundation. The AI pitch, including the Agentic Call Report, comes from Veeva’s product description.
  • 02Veeva says the Agentic Call Report turns field call records into "Commercial Evidence" about treatment barriers that went unseen before. If it works as described, call reports gain value when analyzed at scale.
  • 03No go-live date or financial terms were disclosed. A go-live date or first-market rollout from UCB would show how quickly a worldwide migration is moving.

Nov 7, 2026

Why ISPE put peptide and oligo facility design in one guide

Why ISPE put peptide and oligo facility design in one guide

ISPE's new Baseline Guide covers oligonucleotide and peptide facility design in one document, says Jim Love of CRB. It pairs a GMP survey of existing plants with a sustainability outlook and a piping safety framework for scale-up, while FDA's oligonucleotide guidances under dockets opened in 2022 and 2024 remain the regulator's own reference.

  • 01Peptide plants inherited API chemistry thinking and oligo plants biotech thinking; ISPE’s guide puts both modalities in one facility document with both inheritances.
  • 02The guide has three parts: a GMP survey of existing oligo and peptide plants, a forecast of how sustainability and scale will change the processes, and a safety framework for connective piping and equipment.
  • 03FDA keeps its own oligonucleotide-specific guidances under dockets opened in 2022 and 2024, so the ISPE guide works as an industry consensus alongside regulation rather than in place of it.

Nov 5, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512